DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Relative fluorescent unit are 16

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_0270	Nalidixic Acid	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/New Jersey/15/2007		Relative fluorescent unit	Decrease (50 %)	Approved, Investigational	26833677
DrugRepV_0271	Nalidixic Acid	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/Netherlands/026/2008		Relative fluorescent unit	Decrease (50 %)	Approved, Investigational	26833677
DrugRepV_0272	Nalidixic Acid	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/Netherlands /049/2008		Relative fluorescent unit	No significant effect (50 %)	Approved, Investigational	26833677
DrugRepV_0273	Nalidixic Acid	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/Brisbane/59/2007		Relative fluorescent unit	No significant effect (50 %)	Approved, Investigational	26833677
DrugRepV_0276	Dorzolamide	Sensory Organ	Open-angle glaucoma and ocular hypertension	Influenza virus	A/New Jersey/15/2007		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0277	Dorzolamide	Sensory Organ	Open-angle glaucoma and ocular hypertension	Influenza virus	A/Netherlands/026/2008		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0278	Dorzolamide	Sensory Organ	Open-angle glaucoma and ocular hypertension	Influenza virus	A/Netherlands /049/2008		Relative fluorescent unit	No significant effect (50 %)	Approved	26833677
DrugRepV_0279	Dorzolamide	Sensory Organ	Open-angle glaucoma and ocular hypertension	Influenza virus	A/Brisbane/59/2007		Relative fluorescent unit	No significant effect (50 %)	Approved	26833677
DrugRepV_0282	Diclofenac	Dermatologicals; Musculo-Skeletal System and Sensory Organ	Fever and pain	Influenza virus	A/New Jersey/15/2007		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0283	Diclofenac	Dermatologicals; Musculo-Skeletal System and Sensory Organ	Fever and pain	Influenza virus	A/Netherlands/026/2008		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0284	Diclofenac	Dermatologicals; Musculo-Skeletal System and Sensory Organ	Fever and pain	Influenza virus	A/Netherlands /049/2008		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0285	Diclofenac	Dermatologicals; Musculo-Skeletal System and Sensory Organ	Fever and pain	Influenza virus	A/Brisbane /56/2007		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0286	Imipenem	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/New Jersey/15/2007		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0287	Imipenem	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/Netherlands/026/2008		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0288	Imipenem	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/Netherlands /049/2008		Relative fluorescent unit	Decrease (50 %)	Approved	26833677
DrugRepV_0289	Imipenem	Antiinfectives For Systemic Use	Bacterial infections	Influenza virus	A/Brisbane /56/2007		Relative fluorescent unit	Decrease (50 %)	Approved	26833677